Analysis of the price of abatacept (Enrisu) and price differences in different regions

Abatacept is a selective T cell costimulation modulator, mainly used to treat rheumatoid arthritis and other autoimmune diseases. In China, abatacept is already on the market, but it has not yet been included in the medical insurance reimbursement system, so patients need to bear the cost of the drug themselves. The current domestic price of a bottle of abatacept is about six to seven thousand yuan. The specific price may vary depending on different hospitals, pharmacies and purchasing channels. Patients should consult local pharmacies or hospitals to obtain accurate price information before purchasing.

In overseas markets, there are certain differences in the price of abatacept. For example, the price of original drugs sold in the Turkish market is relatively cheap, about more than more than 5,000 yuan each, which is lower than the price in the domestic market. At the same time, drug procurement and distribution models in some foreign countries may make the prices of original drugs more flexible, while regulatory policies, tariffs and distribution costs for biological agents in different regions will also affect the final selling price.

The price difference between domestic and foreign countries is mainly affected by the following factors:

1. Medical insurance coverage and reimbursement policy: It has not been included in domestic medical insurance, and all costs are paid by the patient; in some foreign markets, there may be partial reimbursement by the government or insurance.

2.Drug distribution and taxes: Imported drugs need to pay tariffs and distribution costs domestically, but in some countries such as Turkey, the costs are lower due to preferential policies or direct import channels.

3.Market competition and procurement strategies: Different regions have different drug supply and demand, market competition, and original drug pricing strategies, which will also lead to obvious price differences.

When purchasing abatacept, patients should comprehensively consider price, formal channels and drug quality assurance. Domestic patients can purchase the drugs at regular hospital pharmacies, ensuring that the drugs are original research or qualified biologics, and pay attention to the storage conditions and validity period. For patients who purchase through overseas channels, they should ensure that the channels are legal to avoid the risk of counterfeit drugs, and pay attention to transportation and storage conditions to ensure the efficacy and safety of the drugs.

Reference link:https://www.drugs.com